| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DRMA | Dermata Therapeutics, Inc. | Kathleen D. Scott | Director | Jun 16, 2026 | Sale | $1.19 | 11 | 13 | 0 | Jun 16, 2026, 04:15 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Aug 21, 2025 | Option/RSU Exercise | $1.50 | 12,500 | 18,750 | 22,542 | Aug 22, 2025, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Aug 21, 2025 | Sale | $15.00 | 12,500 | 187,500 | 10,042 | Aug 22, 2025, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | May 20, 2025 | Option/RSU Exercise | $1.50 | 50,000 | 75,000 | 57,424 | May 22, 2025, 05:00 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | May 20, 2025 | Sale | $14.10 | 50,000 | 705,165 | 7,424 | May 22, 2025, 05:00 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Oct 16, 2024 | Option/RSU Exercise | $1.50 | 12,500 | 18,750 | 17,449 | Oct 17, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Oct 16, 2024 | Sale | $16.00 | 12,500 | 200,000 | 4,949 | Oct 17, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Aug 20, 2024 | Option/RSU Exercise | $1.50 | 12,500 | 18,750 | 25,699 | Aug 21, 2024, 06:49 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Aug 20, 2024 | Sale | $16.00 | 12,500 | 200,000 | 13,199 | Aug 21, 2024, 06:49 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Kathleen D. Scott | Chief Financial Officer | Nov 29, 2022 | Buy | $6.24 | 8,250 | 51,506 | 8,250 | Dec 01, 2022, 04:31 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More